nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—SLCO1B3—Rifampicin—leprosy	0.183	0.224	CbGbCtD
Mycophenolate mofetil—UGT1A1—Rifampicin—leprosy	0.154	0.188	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Rifampicin—leprosy	0.107	0.13	CbGbCtD
Mycophenolate mofetil—ABCC2—Rifampicin—leprosy	0.0937	0.115	CbGbCtD
Mycophenolate mofetil—CYP3A5—Thalidomide—leprosy	0.0484	0.0593	CbGbCtD
Mycophenolate mofetil—CYP3A5—Rifampicin—leprosy	0.0469	0.0574	CbGbCtD
Mycophenolate mofetil—CYP2C8—Rifampicin—leprosy	0.0451	0.0552	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dapsone—leprosy	0.0387	0.0474	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dapsone—leprosy	0.0372	0.0456	CbGbCtD
Mycophenolate mofetil—ABCB1—Rifampicin—leprosy	0.0305	0.0374	CbGbCtD
Mycophenolate mofetil—CYP3A4—Rifampicin—leprosy	0.0183	0.0224	CbGbCtD
Mycophenolate mofetil—CYP3A4—Dapsone—leprosy	0.0151	0.0185	CbGbCtD
Mycophenolate mofetil—Hormone level abnormal—Thalidomide—leprosy	0.00789	0.0442	CcSEcCtD
Mycophenolate mofetil—Retinitis—Thalidomide—leprosy	0.00709	0.0398	CcSEcCtD
Mycophenolate mofetil—Benign neoplasm of skin—Thalidomide—leprosy	0.0055	0.0308	CcSEcCtD
Mycophenolate mofetil—Cholangitis—Thalidomide—leprosy	0.00429	0.024	CcSEcCtD
Mycophenolate mofetil—Peritonitis—Thalidomide—leprosy	0.00295	0.0165	CcSEcCtD
Mycophenolate mofetil—Arterial thrombosis—Thalidomide—leprosy	0.00276	0.0155	CcSEcCtD
Mycophenolate mofetil—Lacrimal structural disorder—Thalidomide—leprosy	0.00253	0.0142	CcSEcCtD
Mycophenolate mofetil—Hypoproteinaemia—Thalidomide—leprosy	0.00253	0.0142	CcSEcCtD
Mycophenolate mofetil—Pyuria—Thalidomide—leprosy	0.00213	0.0119	CcSEcCtD
Mycophenolate mofetil—Albuminuria—Dapsone—leprosy	0.00195	0.0109	CcSEcCtD
Mycophenolate mofetil—Meningitis—Thalidomide—leprosy	0.00192	0.0108	CcSEcCtD
Mycophenolate mofetil—Hypochromic anaemia—Thalidomide—leprosy	0.00192	0.0108	CcSEcCtD
Mycophenolate mofetil—Intestinal perforation—Thalidomide—leprosy	0.00188	0.0106	CcSEcCtD
Mycophenolate mofetil—Fungal skin infection—Thalidomide—leprosy	0.00178	0.00998	CcSEcCtD
Mycophenolate mofetil—Lacrimal disorder—Thalidomide—leprosy	0.00166	0.00933	CcSEcCtD
Mycophenolate mofetil—Ascites—Thalidomide—leprosy	0.00164	0.00918	CcSEcCtD
Mycophenolate mofetil—Hernia—Thalidomide—leprosy	0.00159	0.00889	CcSEcCtD
Mycophenolate mofetil—Cerebral ischaemia—Thalidomide—leprosy	0.00154	0.00863	CcSEcCtD
Mycophenolate mofetil—Peripheral vascular disorder—Thalidomide—leprosy	0.00152	0.0085	CcSEcCtD
Mycophenolate mofetil—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00145	0.00815	CcSEcCtD
Mycophenolate mofetil—Hostility—Thalidomide—leprosy	0.00134	0.00753	CcSEcCtD
Mycophenolate mofetil—Vesiculobullous rash—Thalidomide—leprosy	0.00133	0.00744	CcSEcCtD
Mycophenolate mofetil—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00128	0.00718	CcSEcCtD
Mycophenolate mofetil—Gastric ulcer—Thalidomide—leprosy	0.00128	0.00718	CcSEcCtD
Mycophenolate mofetil—Enlargement abdomen—Thalidomide—leprosy	0.00124	0.00693	CcSEcCtD
Mycophenolate mofetil—Myasthenia—Thalidomide—leprosy	0.00118	0.00663	CcSEcCtD
Mycophenolate mofetil—Hypomagnesaemia—Thalidomide—leprosy	0.00117	0.00656	CcSEcCtD
Mycophenolate mofetil—Oral candidiasis—Thalidomide—leprosy	0.00117	0.00656	CcSEcCtD
Mycophenolate mofetil—Hypothyroidism—Thalidomide—leprosy	0.00116	0.0065	CcSEcCtD
Mycophenolate mofetil—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00109	0.00612	CcSEcCtD
Mycophenolate mofetil—Hypercalcaemia—Thalidomide—leprosy	0.00107	0.006	CcSEcCtD
Mycophenolate mofetil—Interstitial lung disease—Thalidomide—leprosy	0.00105	0.00589	CcSEcCtD
Mycophenolate mofetil—Cyanosis—Thalidomide—leprosy	0.00105	0.00589	CcSEcCtD
Mycophenolate mofetil—Lung disorder—Thalidomide—leprosy	0.00105	0.00589	CcSEcCtD
Mycophenolate mofetil—Thrombosis—Thalidomide—leprosy	0.00105	0.00589	CcSEcCtD
Mycophenolate mofetil—Metrorrhagia—Thalidomide—leprosy	0.00104	0.00584	CcSEcCtD
Mycophenolate mofetil—Nystagmus—Thalidomide—leprosy	0.00104	0.00584	CcSEcCtD
Mycophenolate mofetil—Hyperlipidaemia—Thalidomide—leprosy	0.00103	0.00579	CcSEcCtD
Mycophenolate mofetil—Psychotic disorder—Dapsone—leprosy	0.00103	0.00578	CcSEcCtD
Mycophenolate mofetil—Albuminuria—Thalidomide—leprosy	0.000997	0.00559	CcSEcCtD
Mycophenolate mofetil—Pleural effusion—Thalidomide—leprosy	0.000972	0.00545	CcSEcCtD
Mycophenolate mofetil—Amblyopia—Thalidomide—leprosy	0.000964	0.0054	CcSEcCtD
Mycophenolate mofetil—Skin ulcer—Thalidomide—leprosy	0.000956	0.00536	CcSEcCtD
Mycophenolate mofetil—Hyperaesthesia—Thalidomide—leprosy	0.000948	0.00531	CcSEcCtD
Mycophenolate mofetil—Rash pustular—Thalidomide—leprosy	0.000933	0.00523	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Dapsone—leprosy	0.000931	0.00522	CcSEcCtD
Mycophenolate mofetil—Influenza—Dapsone—leprosy	0.000912	0.00511	CcSEcCtD
Mycophenolate mofetil—Petechiae—Thalidomide—leprosy	0.000905	0.00507	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Dapsone—leprosy	0.000894	0.00501	CcSEcCtD
Mycophenolate mofetil—Blood disorder—Thalidomide—leprosy	0.000891	0.00499	CcSEcCtD
Mycophenolate mofetil—Acne—Thalidomide—leprosy	0.000884	0.00496	CcSEcCtD
Mycophenolate mofetil—Apnoea—Thalidomide—leprosy	0.000878	0.00492	CcSEcCtD
Mycophenolate mofetil—Jaundice cholestatic—Thalidomide—leprosy	0.000847	0.00475	CcSEcCtD
Mycophenolate mofetil—Amenorrhoea—Thalidomide—leprosy	0.000847	0.00475	CcSEcCtD
Mycophenolate mofetil—Accidental injury—Thalidomide—leprosy	0.000841	0.00471	CcSEcCtD
Mycophenolate mofetil—Skin discolouration—Thalidomide—leprosy	0.000824	0.00462	CcSEcCtD
Mycophenolate mofetil—Cellulitis—Thalidomide—leprosy	0.000818	0.00459	CcSEcCtD
Mycophenolate mofetil—Hyperbilirubinaemia—Thalidomide—leprosy	0.000818	0.00459	CcSEcCtD
Mycophenolate mofetil—Arthropathy—Thalidomide—leprosy	0.000818	0.00459	CcSEcCtD
Mycophenolate mofetil—Hypocalcaemia—Thalidomide—leprosy	0.000813	0.00456	CcSEcCtD
Mycophenolate mofetil—Thinking abnormal—Thalidomide—leprosy	0.000813	0.00456	CcSEcCtD
Mycophenolate mofetil—Oliguria—Thalidomide—leprosy	0.000808	0.00453	CcSEcCtD
Mycophenolate mofetil—Herpes simplex—Thalidomide—leprosy	0.000808	0.00453	CcSEcCtD
Mycophenolate mofetil—Hyperuricaemia—Thalidomide—leprosy	0.000802	0.0045	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Dapsone—leprosy	0.000797	0.00447	CcSEcCtD
Mycophenolate mofetil—Leukocytosis—Thalidomide—leprosy	0.000792	0.00444	CcSEcCtD
Mycophenolate mofetil—Hypercholesterolaemia—Thalidomide—leprosy	0.000787	0.00441	CcSEcCtD
Mycophenolate mofetil—Creatinine increased—Thalidomide—leprosy	0.000782	0.00438	CcSEcCtD
Mycophenolate mofetil—Bone pain—Thalidomide—leprosy	0.000777	0.00435	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Dapsone—leprosy	0.000763	0.00428	CcSEcCtD
Mycophenolate mofetil—Blood uric acid increased—Thalidomide—leprosy	0.000758	0.00425	CcSEcCtD
Mycophenolate mofetil—Neck pain—Thalidomide—leprosy	0.000753	0.00422	CcSEcCtD
Mycophenolate mofetil—Phosphatase alkaline increased—Thalidomide—leprosy	0.000744	0.00417	CcSEcCtD
Mycophenolate mofetil—Pulmonary embolism—Thalidomide—leprosy	0.000744	0.00417	CcSEcCtD
Mycophenolate mofetil—Hepatocellular injury—Thalidomide—leprosy	0.000744	0.00417	CcSEcCtD
Mycophenolate mofetil—Eructation—Thalidomide—leprosy	0.000731	0.0041	CcSEcCtD
Mycophenolate mofetil—Hyperkalaemia—Thalidomide—leprosy	0.000731	0.0041	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Dapsone—leprosy	0.000725	0.00406	CcSEcCtD
Mycophenolate mofetil—Colitis—Thalidomide—leprosy	0.000714	0.004	CcSEcCtD
Mycophenolate mofetil—Candida infection—Thalidomide—leprosy	0.00071	0.00398	CcSEcCtD
Mycophenolate mofetil—Blood urea increased—Thalidomide—leprosy	0.000703	0.00394	CcSEcCtD
Mycophenolate mofetil—Aplastic anaemia—Thalidomide—leprosy	0.000699	0.00392	CcSEcCtD
Mycophenolate mofetil—Neuropathy—Thalidomide—leprosy	0.000699	0.00392	CcSEcCtD
Mycophenolate mofetil—Cramps of lower extremities—Thalidomide—leprosy	0.000684	0.00383	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Dapsone—leprosy	0.000681	0.00381	CcSEcCtD
Mycophenolate mofetil—Oesophagitis—Thalidomide—leprosy	0.00068	0.00381	CcSEcCtD
Mycophenolate mofetil—Rash maculo-papular—Thalidomide—leprosy	0.000676	0.00379	CcSEcCtD
Mycophenolate mofetil—Gynaecomastia—Thalidomide—leprosy	0.000666	0.00373	CcSEcCtD
Mycophenolate mofetil—Pulmonary oedema—Thalidomide—leprosy	0.000662	0.00371	CcSEcCtD
Mycophenolate mofetil—Hypertonia—Thalidomide—leprosy	0.000652	0.00366	CcSEcCtD
Mycophenolate mofetil—Hyperkinesia—Thalidomide—leprosy	0.000649	0.00364	CcSEcCtD
Mycophenolate mofetil—Mental disability—Thalidomide—leprosy	0.000646	0.00362	CcSEcCtD
Mycophenolate mofetil—Sepsis—Thalidomide—leprosy	0.000646	0.00362	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Thalidomide—leprosy	0.000633	0.00355	CcSEcCtD
Mycophenolate mofetil—Thrombophlebitis—Thalidomide—leprosy	0.000624	0.0035	CcSEcCtD
Mycophenolate mofetil—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000621	0.00348	CcSEcCtD
Mycophenolate mofetil—Diabetes mellitus—Thalidomide—leprosy	0.000621	0.00348	CcSEcCtD
Mycophenolate mofetil—Gastroenteritis—Thalidomide—leprosy	0.000609	0.00342	CcSEcCtD
Mycophenolate mofetil—Deafness—Thalidomide—leprosy	0.000604	0.00338	CcSEcCtD
Mycophenolate mofetil—Eye pain—Thalidomide—leprosy	0.000598	0.00335	CcSEcCtD
Mycophenolate mofetil—Cardiac failure congestive—Thalidomide—leprosy	0.000596	0.00334	CcSEcCtD
Mycophenolate mofetil—Injury—Thalidomide—leprosy	0.000588	0.00329	CcSEcCtD
Mycophenolate mofetil—Renal failure acute—Thalidomide—leprosy	0.000585	0.00328	CcSEcCtD
Mycophenolate mofetil—Amnesia—Thalidomide—leprosy	0.000575	0.00322	CcSEcCtD
Mycophenolate mofetil—Vertigo—Dapsone—leprosy	0.000571	0.0032	CcSEcCtD
Mycophenolate mofetil—Visual disturbance—Thalidomide—leprosy	0.00057	0.00319	CcSEcCtD
Mycophenolate mofetil—Atrial fibrillation—Thalidomide—leprosy	0.00057	0.00319	CcSEcCtD
Mycophenolate mofetil—Dermatitis bullous—Thalidomide—leprosy	0.000565	0.00317	CcSEcCtD
Mycophenolate mofetil—Cough—Dapsone—leprosy	0.000555	0.00311	CcSEcCtD
Mycophenolate mofetil—Cardiac failure—Thalidomide—leprosy	0.000554	0.0031	CcSEcCtD
Mycophenolate mofetil—Hypoglycaemia—Thalidomide—leprosy	0.000554	0.0031	CcSEcCtD
Mycophenolate mofetil—Cerebrovascular accident—Thalidomide—leprosy	0.000551	0.00309	CcSEcCtD
Mycophenolate mofetil—Hyponatraemia—Thalidomide—leprosy	0.000542	0.00304	CcSEcCtD
Mycophenolate mofetil—Osteoarthritis—Thalidomide—leprosy	0.00054	0.00303	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00054	0.00303	CcSEcCtD
Mycophenolate mofetil—Diplopia—Thalidomide—leprosy	0.00054	0.00303	CcSEcCtD
Mycophenolate mofetil—Affect lability—Thalidomide—leprosy	0.000532	0.00298	CcSEcCtD
Mycophenolate mofetil—Psychotic disorder—Thalidomide—leprosy	0.000528	0.00296	CcSEcCtD
Mycophenolate mofetil—Face oedema—Thalidomide—leprosy	0.000522	0.00292	CcSEcCtD
Mycophenolate mofetil—Cardiac arrest—Thalidomide—leprosy	0.000514	0.00288	CcSEcCtD
Mycophenolate mofetil—Mood swings—Thalidomide—leprosy	0.000512	0.00287	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Dapsone—leprosy	0.000506	0.00284	CcSEcCtD
Mycophenolate mofetil—Blood creatinine increased—Thalidomide—leprosy	0.000506	0.00284	CcSEcCtD
Mycophenolate mofetil—Dehydration—Thalidomide—leprosy	0.000502	0.00282	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Thalidomide—leprosy	0.000499	0.00279	CcSEcCtD
Mycophenolate mofetil—Orthostatic hypotension—Thalidomide—leprosy	0.000493	0.00276	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Thalidomide—leprosy	0.000492	0.00276	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000486	0.00273	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Thalidomide—leprosy	0.000476	0.00267	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Thalidomide—leprosy	0.000476	0.00267	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Thalidomide—leprosy	0.00047	0.00263	CcSEcCtD
Mycophenolate mofetil—Insomnia—Dapsone—leprosy	0.000469	0.00263	CcSEcCtD
Mycophenolate mofetil—Influenza—Thalidomide—leprosy	0.000467	0.00262	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Thalidomide—leprosy	0.000467	0.00262	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Thalidomide—leprosy	0.000458	0.00257	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Thalidomide—leprosy	0.000455	0.00255	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Thalidomide—leprosy	0.000449	0.00252	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Thalidomide—leprosy	0.000443	0.00248	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Thalidomide—leprosy	0.000437	0.00245	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Thalidomide—leprosy	0.000431	0.00242	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Thalidomide—leprosy	0.00043	0.00241	CcSEcCtD
Mycophenolate mofetil—Weight increased—Thalidomide—leprosy	0.000425	0.00238	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dapsone—leprosy	0.000424	0.00238	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Thalidomide—leprosy	0.000422	0.00237	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Thalidomide—leprosy	0.000421	0.00236	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Thalidomide—leprosy	0.000419	0.00235	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Thalidomide—leprosy	0.000416	0.00233	CcSEcCtD
Mycophenolate mofetil—Infestation—Thalidomide—leprosy	0.000416	0.00233	CcSEcCtD
Mycophenolate mofetil—Depression—Thalidomide—leprosy	0.000415	0.00233	CcSEcCtD
Mycophenolate mofetil—Acute coronary syndrome—Thalidomide—leprosy	0.00041	0.0023	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dapsone—leprosy	0.00041	0.0023	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dapsone—leprosy	0.00041	0.0023	CcSEcCtD
Mycophenolate mofetil—Renal failure—Thalidomide—leprosy	0.000409	0.00229	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Thalidomide—leprosy	0.000408	0.00229	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Thalidomide—leprosy	0.000408	0.00229	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Thalidomide—leprosy	0.000406	0.00227	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Thalidomide—leprosy	0.000405	0.00227	CcSEcCtD
Mycophenolate mofetil—Sweating—Thalidomide—leprosy	0.000399	0.00224	CcSEcCtD
Mycophenolate mofetil—Haematuria—Thalidomide—leprosy	0.000397	0.00222	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Thalidomide—leprosy	0.000393	0.0022	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Thalidomide—leprosy	0.000391	0.00219	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Thalidomide—leprosy	0.000388	0.00218	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Thalidomide—leprosy	0.00038	0.00213	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Thalidomide—leprosy	0.000375	0.0021	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Thalidomide—leprosy	0.000374	0.00209	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Thalidomide—leprosy	0.000372	0.00208	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Thalidomide—leprosy	0.000371	0.00208	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Thalidomide—leprosy	0.000369	0.00207	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Thalidomide—leprosy	0.000368	0.00206	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Thalidomide—leprosy	0.000366	0.00205	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Thalidomide—leprosy	0.00036	0.00202	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Thalidomide—leprosy	0.000349	0.00196	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Thalidomide—leprosy	0.000348	0.00195	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Thalidomide—leprosy	0.000347	0.00194	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Thalidomide—leprosy	0.000339	0.0019	CcSEcCtD
Mycophenolate mofetil—UGT1A6—testis—leprosy	0.000338	0.0817	CbGeAlD
Mycophenolate mofetil—Mediastinal disorder—Thalidomide—leprosy	0.000337	0.00189	CcSEcCtD
Mycophenolate mofetil—Chills—Thalidomide—leprosy	0.000335	0.00188	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Thalidomide—leprosy	0.000334	0.00187	CcSEcCtD
Mycophenolate mofetil—Alopecia—Thalidomide—leprosy	0.00033	0.00185	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dapsone—leprosy	0.00033	0.00185	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Thalidomide—leprosy	0.000327	0.00183	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Thalidomide—leprosy	0.000325	0.00182	CcSEcCtD
Mycophenolate mofetil—Headache—Dapsone—leprosy	0.000325	0.00182	CcSEcCtD
Mycophenolate mofetil—Flatulence—Thalidomide—leprosy	0.000321	0.0018	CcSEcCtD
Mycophenolate mofetil—Tension—Thalidomide—leprosy	0.000319	0.00179	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Thalidomide—leprosy	0.000319	0.00179	CcSEcCtD
Mycophenolate mofetil—Nervousness—Thalidomide—leprosy	0.000316	0.00177	CcSEcCtD
Mycophenolate mofetil—Back pain—Thalidomide—leprosy	0.000315	0.00176	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Thalidomide—leprosy	0.000313	0.00175	CcSEcCtD
Mycophenolate mofetil—Nausea—Dapsone—leprosy	0.000308	0.00173	CcSEcCtD
Mycophenolate mofetil—Tremor—Thalidomide—leprosy	0.000305	0.00171	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Thalidomide—leprosy	0.000302	0.00169	CcSEcCtD
Mycophenolate mofetil—Anaemia—Thalidomide—leprosy	0.000301	0.00169	CcSEcCtD
Mycophenolate mofetil—Agitation—Thalidomide—leprosy	0.000299	0.00168	CcSEcCtD
Mycophenolate mofetil—Angioedema—Thalidomide—leprosy	0.000297	0.00167	CcSEcCtD
Mycophenolate mofetil—IMPDH2—eye—leprosy	0.000295	0.0713	CbGeAlD
Mycophenolate mofetil—Malaise—Thalidomide—leprosy	0.000293	0.00164	CcSEcCtD
Mycophenolate mofetil—IMPDH1—eye—leprosy	0.000293	0.0709	CbGeAlD
Mycophenolate mofetil—Vertigo—Thalidomide—leprosy	0.000292	0.00164	CcSEcCtD
Mycophenolate mofetil—Syncope—Thalidomide—leprosy	0.000292	0.00163	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Thalidomide—leprosy	0.000291	0.00163	CcSEcCtD
Mycophenolate mofetil—Palpitations—Thalidomide—leprosy	0.000287	0.00161	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Thalidomide—leprosy	0.000286	0.0016	CcSEcCtD
Mycophenolate mofetil—Cough—Thalidomide—leprosy	0.000284	0.00159	CcSEcCtD
Mycophenolate mofetil—Convulsion—Thalidomide—leprosy	0.000282	0.00158	CcSEcCtD
Mycophenolate mofetil—Hypertension—Thalidomide—leprosy	0.000281	0.00157	CcSEcCtD
Mycophenolate mofetil—Myalgia—Thalidomide—leprosy	0.000277	0.00155	CcSEcCtD
Mycophenolate mofetil—Chest pain—Thalidomide—leprosy	0.000277	0.00155	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Thalidomide—leprosy	0.000277	0.00155	CcSEcCtD
Mycophenolate mofetil—Anxiety—Thalidomide—leprosy	0.000276	0.00155	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000275	0.00154	CcSEcCtD
Mycophenolate mofetil—Discomfort—Thalidomide—leprosy	0.000274	0.00153	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Thalidomide—leprosy	0.000271	0.00152	CcSEcCtD
Mycophenolate mofetil—CES2—eye—leprosy	0.000268	0.0648	CbGeAlD
Mycophenolate mofetil—Confusional state—Thalidomide—leprosy	0.000268	0.0015	CcSEcCtD
Mycophenolate mofetil—Oedema—Thalidomide—leprosy	0.000265	0.00149	CcSEcCtD
Mycophenolate mofetil—Infection—Thalidomide—leprosy	0.000264	0.00148	CcSEcCtD
Mycophenolate mofetil—Shock—Thalidomide—leprosy	0.000261	0.00146	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Thalidomide—leprosy	0.00026	0.00146	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Thalidomide—leprosy	0.00026	0.00146	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Thalidomide—leprosy	0.000259	0.00145	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Thalidomide—leprosy	0.000258	0.00145	CcSEcCtD
Mycophenolate mofetil—IMPDH2—skin of body—leprosy	0.000257	0.0621	CbGeAlD
Mycophenolate mofetil—Hyperhidrosis—Thalidomide—leprosy	0.000257	0.00144	CcSEcCtD
Mycophenolate mofetil—Anorexia—Thalidomide—leprosy	0.000253	0.00142	CcSEcCtD
Mycophenolate mofetil—Hypotension—Thalidomide—leprosy	0.000248	0.00139	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Thalidomide—leprosy	0.000242	0.00136	CcSEcCtD
Mycophenolate mofetil—Insomnia—Thalidomide—leprosy	0.00024	0.00135	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Thalidomide—leprosy	0.000238	0.00134	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Thalidomide—leprosy	0.000237	0.00133	CcSEcCtD
Mycophenolate mofetil—Somnolence—Thalidomide—leprosy	0.000236	0.00132	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Thalidomide—leprosy	0.000234	0.00131	CcSEcCtD
Mycophenolate mofetil—CES2—skin of body—leprosy	0.000233	0.0564	CbGeAlD
Mycophenolate mofetil—Decreased appetite—Thalidomide—leprosy	0.000231	0.00129	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Thalidomide—leprosy	0.000229	0.00128	CcSEcCtD
Mycophenolate mofetil—Pain—Thalidomide—leprosy	0.000227	0.00127	CcSEcCtD
Mycophenolate mofetil—Constipation—Thalidomide—leprosy	0.000227	0.00127	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Thalidomide—leprosy	0.000219	0.00123	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Thalidomide—leprosy	0.000217	0.00122	CcSEcCtD
Mycophenolate mofetil—Urticaria—Thalidomide—leprosy	0.000211	0.00118	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Thalidomide—leprosy	0.00021	0.00118	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Thalidomide—leprosy	0.00021	0.00118	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Thalidomide—leprosy	0.000196	0.0011	CcSEcCtD
Mycophenolate mofetil—IMPDH2—tendon—leprosy	0.000195	0.0472	CbGeAlD
Mycophenolate mofetil—IMPDH1—tendon—leprosy	0.000194	0.047	CbGeAlD
Mycophenolate mofetil—Asthenia—Thalidomide—leprosy	0.00019	0.00107	CcSEcCtD
Mycophenolate mofetil—Pruritus—Thalidomide—leprosy	0.000188	0.00105	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Thalidomide—leprosy	0.000182	0.00102	CcSEcCtD
Mycophenolate mofetil—CES2—tendon—leprosy	0.000178	0.0429	CbGeAlD
Mycophenolate mofetil—Dizziness—Thalidomide—leprosy	0.000176	0.000984	CcSEcCtD
Mycophenolate mofetil—Vomiting—Thalidomide—leprosy	0.000169	0.000946	CcSEcCtD
Mycophenolate mofetil—Rash—Thalidomide—leprosy	0.000167	0.000938	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Thalidomide—leprosy	0.000167	0.000937	CcSEcCtD
Mycophenolate mofetil—Headache—Thalidomide—leprosy	0.000166	0.000932	CcSEcCtD
Mycophenolate mofetil—IMPDH2—testis—leprosy	0.000162	0.0391	CbGeAlD
Mycophenolate mofetil—IMPDH1—testis—leprosy	0.000161	0.0389	CbGeAlD
Mycophenolate mofetil—IMPDH2—nervous system—leprosy	0.000159	0.0384	CbGeAlD
Mycophenolate mofetil—IMPDH1—nervous system—leprosy	0.000158	0.0382	CbGeAlD
Mycophenolate mofetil—Nausea—Thalidomide—leprosy	0.000158	0.000884	CcSEcCtD
Mycophenolate mofetil—CES2—testis—leprosy	0.000147	0.0356	CbGeAlD
Mycophenolate mofetil—UGT2B7—testis—leprosy	0.000147	0.0356	CbGeAlD
Mycophenolate mofetil—CES2—nervous system—leprosy	0.000144	0.0349	CbGeAlD
Mycophenolate mofetil—CES1—testis—leprosy	0.000121	0.0293	CbGeAlD
Mycophenolate mofetil—CES1—nervous system—leprosy	0.000119	0.0287	CbGeAlD
Mycophenolate mofetil—ABCB1—blood vessel—leprosy	9.72e-05	0.0235	CbGeAlD
Mycophenolate mofetil—ABCC2—tendon—leprosy	9.53e-05	0.023	CbGeAlD
Mycophenolate mofetil—ALB—testis—leprosy	8.42e-05	0.0204	CbGeAlD
Mycophenolate mofetil—ABCC2—testis—leprosy	7.89e-05	0.0191	CbGeAlD
Mycophenolate mofetil—CYP2C8—testis—leprosy	5.92e-05	0.0143	CbGeAlD
Mycophenolate mofetil—ABCG2—testis—leprosy	5.75e-05	0.0139	CbGeAlD
Mycophenolate mofetil—CYP3A4—nervous system—leprosy	3.93e-05	0.00951	CbGeAlD
Mycophenolate mofetil—ABCB1—testis—leprosy	2.84e-05	0.00686	CbGeAlD
Mycophenolate mofetil—ABCB1—nervous system—leprosy	2.78e-05	0.00673	CbGeAlD
